Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles

被引：143

作者：

Hall, Brett

Dembinski, Jennifer

Sasser, A. Kate

Studeny, Matus

Andreeff, Michael

Marini, Frank

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Unit 81, Houston, TX 77030 USA

[2] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA

[3] Columbus Childrens Res Inst, Ctr Childhood Canc, Columbus, OH USA

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2007年 / 86卷 / 01期

关键词：

mesenchymal stem cells; tumor microenvironment; stroma; vascular network; gene therapy;

D O I：

10.1532/IJH97.06230

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors, where they contribute to the formation of tumor-associated stroma. This effect can be opposed by genetically modifying MSC to produce high levels of anticancer agents that blunt tumor growth kinetics and inhibit the growth of tumors in situ. In this review article, we describe the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.

引用

页码：8 / 16

页数：9

共 138 条

[51] Cells as vehicles for cancer gene therapy: The missing link between targeted vectors and systemic delivery? [J].

Harrington, K ;

Alvarez-Vallina, L ;

Crittenden, M ;

Gough, M ;

Chong, H ;

Diaz, RM ;

Vassaux, G ;

Lemoine, N ;

Vile, R .

HUMAN GENE THERAPY, 2002, 13 (11) :1263-1280

[52] New prognostic histological parameter of invasive ductal carcinoma of the breast: Clinicopathological significance of fibrotic focus [J].

Hasebe, T ;

Mukai, K ;

Tsuda, H ;

Ochiai, A .

PATHOLOGY INTERNATIONAL, 2000, 50 (04) :263-272

[53] Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis [J].

Hill, R ;

Song, YR ;

Cardiff, RD ;

Van Dyke, T .

CELL, 2005, 123 (06) :1001-1011

[54] Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells [J].

Hombauer, H ;

Minguell, JJ .

BRITISH JOURNAL OF CANCER, 2000, 82 (07) :1290-1296

[55] Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat [J].

Honma, T. ;

Honmou, O. ;

Iihoshi, S. ;

Harada, K. ;

Houkin, K. ;

Hamada, H. ;

Kocsis, J. D. .

EXPERIMENTAL NEUROLOGY, 2006, 199 (01) :56-66

[56] Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [J].

Horwitz, EM ;

Prockop, DJ ;

Fitzpatrick, LA ;

Koo, WWK ;

Gordon, PL ;

Neel, M ;

Sussman, M ;

Orchard, P ;

Marx, JC ;

Pyeritz, RE ;

Brenner, MK .

NATURE MEDICINE, 1999, 5 (03) :309-313

[57] Gastric cancer originating from bone marrow-derived cells [J].

Houghton, J ;

Stoicov, C ;

Nomura, S ;

Rogers, AB ;

Carlson, J ;

Li, HC ;

Cai, X ;

Fox, JG ;

Goldenring, JR ;

Wang, TC .

SCIENCE, 2004, 306 (5701) :1568-1571

[58] Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells [J].

Hurwitz, DR ;

Kirchgesser, M ;

Merrill, W ;

Galanopoulos, T ;

McGrath, CA ;

Emami, S ;

Hansen, M ;

Cherington, V ;

Appel, JM ;

Bizinkauskas, CB ;

Brackmann, HH ;

Levine, PH ;

Greenberger, JS .

HUMAN GENE THERAPY, 1997, 8 (02) :137-156

[59]

Iacobuzio-Donahue CA, 2002, CANCER RES, V62, P5351

[60] Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta [J].

in't Anker, PS ;

Scherjon, SA ;

Kleijburg-van der Keur, C ;

de Groot-Swings, GMJS ;

Claas, FHJ ;

Fibbe, WE ;

Kanhai, HHH .

STEM CELLS, 2004, 22 (07) :1338-1345

← 1 2 3 4 5 6 7 8 9 10 →